Literature DB >> 8205240

Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.

C Holmes1, G Eisenhofer, D S Goldstein.   

Abstract

Several modifications of an HPLC-electrochemical assay method for plasma levels of norepinephrine (NE), epinephrine (EPI), dopamine (DA), dihydroxyphenylglycol (DHPG), dihydroxyphenylalanine (DOPA) and dihydroxyphenylacetic acid (DOPAC) that improve the accuracy and reliability of DHPG, DOPA, and DOPAC measurements are described. In batch alumina extractions, increasing the amount of alumina decreased analytical recoveries of DHPG, DOPA, and especially DOPAC, and increasing the strength of the eluting acid increased recoveries of these catechols, without affecting recoveries of the amines NE, EPI and DA. Refrigeration (4 degrees C) until injection stabilized DOPAC in aqueous solution and therefore improved the reproducibility of plasma DOPAC measurements. Circulation of chilled water (15 degrees C) around the column using a water jacket decreased variability in retention times of the catechols and thereby facilitated identification of peaks, while enhancing separation of DHPG from the solvent front. Use of 6-fluoro-DOPA and 6-fluoro-DOPAC as internal standards did not improve inter-assay reliability. We recommend that in assays of plasma catechols including DOPAC, small (5 mg), precisely measured amounts of alumina be used, with a relatively strong eluting solution (e.g. 0.04 M phosphoric acid-0.2 M acetic acid, 20:80, v/v), and that the samples be refrigerated until injection, with column temperature held constant at less than 20 degrees C.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205240     DOI: 10.1016/0378-4347(93)e0430-x

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  69 in total

1.  Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.

Authors:  Mei Sun; Guo-Rong Zhang; Lingxin Kong; Courtney Holmes; Xiaodan Wang; Wei Zhang; David S Goldstein; Alfred I Geller
Journal:  Hum Gene Ther       Date:  2003-03-20       Impact factor: 5.695

2.  Catechols in post-mortem brain of patients with Parkinson disease.

Authors:  D S Goldstein; P Sullivan; C Holmes; I J Kopin; M J Basile; D C Mash
Journal:  Eur J Neurol       Date:  2010-11-12       Impact factor: 6.089

3.  Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.

Authors:  Tonya N Taylor; Shawn P Alter; Minzheng Wang; David S Goldstein; Gary W Miller
Journal:  Neuropharmacology       Date:  2013-09-08       Impact factor: 5.250

4.  Dopamine contamination of infused tyramine.

Authors:  Courtney Holmes; Jeffrey Moak; Basil Eldadah; Ella Zimmerly; Yehonatan Sharabi; David S Goldstein
Journal:  Clin Chem       Date:  2005-07-21       Impact factor: 8.327

5.  Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension.

Authors:  Kimberly Gilbert; Hui Nian; Chang Yu; James M Luther; Nancy J Brown
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

6.  Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.

Authors:  David S Goldstein; Courtney S Holmes; Stephen G Kaler
Journal:  Neurochem Res       Date:  2009-02-21       Impact factor: 3.996

7.  Cardiac ectopy in chronic autonomic failure.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2009-12-11       Impact factor: 4.435

8.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

9.  Association of anosmia with autonomic failure in Parkinson disease.

Authors:  David S Goldstein; LaToya Sewell; Courtney Holmes
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

10.  Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.

Authors:  David S Goldstein; Patti Sullivan; Adele Cooney; Yunden Jinsmaa; Rachel Sullivan; Daniel J Gross; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Neurochem       Date:  2012-10-25       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.